PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 5 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240 | -59.9% | 7,749 | -48.2% | 0.05% | -58.2% |
| Q2 2023 | $598 | -65.0% | 14,953 | -64.1% | 0.11% | -67.6% |
| Q1 2023 | $1,709 | +4.5% | 41,688 | -0.5% | 0.34% | -4.2% |
| Q4 2022 | $1,635 | -99.9% | 41,918 | -3.4% | 0.35% | -33.6% |
| Q3 2022 | $2,299,000 | +24.5% | 43,378 | +36.2% | 0.53% | +28.1% |
| Q2 2022 | $1,847,000 | +689.3% | 31,844 | +932.2% | 0.42% | +845.5% |
| Q1 2022 | $234,000 | – | 3,085 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |